Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib - MD Linx

Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib  MD Linx

Comments

Popular posts from this blog

Medical Review Board

Top Doctors List 2021 | HOUR Detroit Magazine